Abstract
Background Observational studies of raised dietary antioxidants suggest a beneficial effect on health, but the results from interventional studies generally show no effect. There are no robust studies targeting people exposed to high levels of environmental oxidants where any effects of raised antioxidants are plausibly stronger.
Objectives To examine whether people genetically predisposed to raised dietary serum antioxidants have improved respiratory health.
Methods We identified single-nucleotide polymorphisms (SNPs) associated with serum ascorbate (vitamin C), retinol (vitamin A), and β-carotene from external data sources. Outcome data on forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), were derived from individual-level data from over 285,000 UK Biobank participants. We used linear regression to explore relationships between the SNPs and lung function. To quantify any relationships, we instrumented the association using exposure beta coefficient from published literature and genome wide association studies (Mendelian randomization).
Results We found no consistent relationship between genetically raised serum antioxidant levels and respiratory health measures. There was no evidence of effect modification by exposures linked to oxidative stress including cigarette smoke, air pollution and poor diet.
Conclusions Our findings support interventional studies showing no causal relationship between dietary antioxidants and respiratory disease outcomes. Further, our results do not support interventions to increase serum levels of ascorbate, retinol, or β-carotene in people exposed to high levels of environmental oxidants (Wellcome Grant ID: 209207/Z/17/Z and 225195/Z/22/Z).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded in whole, or in part, by the Wellcome Trust [Grant number 209207/Z/17/Z and 225195/Z/22/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank has ongoing approval from the North West Multi-centre Research Ethics Committee as a Research Tissue Bank (RTB) approval. This approval means that researchers do not require separate ethical clearance and can carry out research under the RTB approval. The present study protocol has been approved by UK Biobank (ID: 5167).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
The data supporting this study’s findings are available from UK Biobank (https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access). Restrictions apply to the availability of these data under Material Transfer Agreements.
